Skip to main content
10x Genomics, Inc. (TXG)
NASDAQ: TXG · Real-Time Price · USD
14.04
+0.43 (3.16%)
At close: Dec 20, 2024, 4:00 PM
13.95
-0.09 (-0.64%)
After-hours: Dec 20, 2024, 4:20 PM EST

10x Genomics Revenue

10x Genomics had revenue of $151.65M in the quarter ending September 30, 2024, a decrease of -1.30%. This brings the company's revenue in the last twelve months to $629.74M, up 6.56% year-over-year. In the year 2023, 10x Genomics had annual revenue of $618.73M with 19.81% growth.

Revenue (ttm)
$629.74M
Revenue Growth
+6.56%
P/S Ratio
2.67
Revenue / Employee
$500,193
Employees
1,259
Market Cap
1.70B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023618.73M102.32M19.81%
Dec 31, 2022516.41M25.92M5.28%
Dec 31, 2021490.49M191.65M64.13%
Dec 31, 2020298.85M52.95M21.53%
Dec 31, 2019245.89M99.58M68.06%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Fortrea Holdings 2.98B
Teladoc Health 2.59B
Clover Health Investments 2.12B
Integra LifeSciences Holdings 1.56B
Evotec SE 866.67M
BioCryst Pharmaceuticals 412.58M
Dynavax Technologies 260.81M
Arcutis Biotherapeutics 138.71M
Revenue Rankings

TXG News

More News